Global equities have advanced as investors have weighed the worsening coronavirus pandemic against hopes of a potential coronavirus vaccine. As sentiment rises, however, we believe it makes sense to be prudent in terms of portfolio positioning. To be clear, we are optimistic as we look out over one to two years, but we are seeing a second wave of the virus spread, and it is proving to be more extended than the first wave in many places. Vaccine developments are a clear positive, but the market's reaction to the prospect of a post‑coronavirus world creates some near‑term uncertainty and risk.
Striking the Right Balance
One question on investors' minds is that of value versus growth. Thoughts of a post‑coronavirus world understandably cause excitement and rotation toward all things "cheap." However, if the economic recovery is disrupted for any prolonged period, markets may favor the Covid‑on beneficiaries, which tend to sit on the growth side of the style spectrum.
For us, it is not a matter of timing a style cycle. We do not think this is the time to make a call on value versus growth. Instead, we believe the key is to maintain portfolio breadth, diversification and apply risk control and active stock‑decision making as we work through what is going to be an uneven path of recovery and improvement. Valuations are important and we need to manage pockets of excessive optimism, along with any uncertainty that arises with respect to U.S. policymaking.
For professional clients only. Not for further distribution.
This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
It is not intended for distribution to retail investors in any jurisdiction.
This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
© 2020 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc.